U.S. flag

An official website of the United States government

NM_001371904.1(APOA5):c.990_993del (p.Asp332fs) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Dec 19, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001256823.4

Allele description [Variation Report for NM_001371904.1(APOA5):c.990_993del (p.Asp332fs)]

NM_001371904.1(APOA5):c.990_993del (p.Asp332fs)

Gene:
APOA5:apolipoprotein A5 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
11q23.3
Genomic location:
Preferred name:
NM_001371904.1(APOA5):c.990_993del (p.Asp332fs)
HGVS:
  • NC_000011.10:g.116790236TGTT[1]
  • NG_015894.2:g.7178AACA[1]
  • NM_001166598.2:c.990_993del
  • NM_001371904.1:c.990_993delMANE SELECT
  • NM_052968.5:c.990_993del
  • NP_001160070.1:p.Asp332fs
  • NP_001358833.1:p.Asp332fs
  • NP_443200.2:p.Asp332fs
  • NC_000011.10:g.116790236_116790239delTGTT
  • NC_000011.9:g.116660952TGTT[1]
  • NC_000011.9:g.116660952_116660955del
  • NG_015894.1:g.7178AACA[1]
  • NM_052968.4:c.990_993delAACA
Protein change:
D332fs
Links:
dbSNP: rs774150500
NCBI 1000 Genomes Browser:
rs774150500
Molecular consequence:
  • NM_001166598.2:c.990_993del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001371904.1:c.990_993del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_052968.5:c.990_993del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001433290Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 21, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004294940Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 19, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Clinical features and genetic analysis of three patients with severe hypertriglyceridaemia.

Hooper AJ, Kurtkoti J, Hamilton-Craig I, Burnett JR.

Ann Clin Biochem. 2014 Jul;51(Pt 4):485-9. doi: 10.1177/0004563214525767. Epub 2014 Mar 3.

PubMed [citation]
PMID:
24591733
See all PubMed Citations (6)

Details of each submission

From Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute, SCV001433290.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004294940.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change creates a premature translational stop signal (p.Asp332Valfs*5) in the APOA5 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 35 amino acid(s) of the APOA5 protein. This variant is present in population databases (rs774150500, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with APOA5-related conditions (PMID: 23307945, 24591733, 29748148, 30420299; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.Q330Q fs X6. ClinVar contains an entry for this variant (Variation ID: 978324). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects APOA5 function (PMID: 23307945). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024